Novasep makes new appointment
This article was originally published in Scrip
Novasep (France) has appointed Kevin Daleysales director, Finorga and Séripharm. He will be responsible for the worldwide sales from Novasep Synthesis' France-based sites. This includes the Finorga cGMP custom development and manufacturing activities at Chasse-sur-Rhone & Mourenx, custom purification activities at Pompey and the Séripharm HPAI synthesis and purification business based in Le Mans. Mr Daley has more than 25 years' experience in the fine chemicals and pharmaceutical custom manufacturing industries.